Current guidelines for the diagnosis and treatment of osteoporosis do not address the risks to bone density and the likelihood of fracture that may be associated with inhaled corticosteroid treatment for asthma. This review outlines an approach to the use of bone densitometry in clinical practice for the diagnosis, prevention, and treatment of osteoporosis in asthmatic patients receiving inhaled corticosteroid therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225820 | PMC |
| http://dx.doi.org/10.1186/1710-1492-1-1-28 | DOI Listing |
Publication Analysis
Top Keywords
treatment osteoporosis
8
inhaled corticosteroid
8
asthma therapeutics
4
therapeutics inhaled
4
inhaled corticosteroids
4
corticosteroids corticosteroid
4
corticosteroid osteoporosis
4
osteoporosis risk
4
risk fracture
4
fracture chronic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!